1010 related articles for article (PubMed ID: 33069259)
1. Development and validation of Nomograms for predicting overall survival and Cancer-specific survival in patients with ovarian clear cell carcinoma.
Chen Q; Wang S; Lang JH
J Ovarian Res; 2020 Oct; 13(1):123. PubMed ID: 33069259
[TBL] [Abstract][Full Text] [Related]
2. Construction and validation of log odds of positive lymph nodes (LODDS)-based nomograms for predicting overall survival and cancer-specific survival in ovarian clear cell carcinoma patients.
Liu Z; Jing C; Hooblal YM; Yang H; Chen Z; Kong F
Front Oncol; 2024; 14():1370272. PubMed ID: 38577328
[TBL] [Abstract][Full Text] [Related]
3. Developing and validating a prognostic nomogram for ovarian clear cell carcinoma patients: A retrospective comparison of lymph node staging schemes with competing risk analysis.
Li Y; Xiu L; Ma M; Seery S; Lou X; Li K; Wu Y; Liang S; Wu Y; Cui W
Front Oncol; 2022; 12():940601. PubMed ID: 36439411
[TBL] [Abstract][Full Text] [Related]
4. Nomograms for predicting overall survival and cancer-specific survival in elderly patients with epithelial ovarian cancer.
Cheng H; Xu JH; Kang XH; Wu CC; Tang XN; Chen ML; Lian ZS; Li N; Xu XL
J Ovarian Res; 2023 Apr; 16(1):75. PubMed ID: 37059991
[TBL] [Abstract][Full Text] [Related]
5. Nomograms for Predicting Overall Survival and Cancer-Specific Survival of Young Patients with Epithelial Ovarian Cancer: Analysis Based on SEER Program.
Gao J; Wang S; Li F; Xu H; Li X; Yan L; Zhu L
Adv Ther; 2022 Jan; 39(1):257-285. PubMed ID: 34716558
[TBL] [Abstract][Full Text] [Related]
6. Development and external validation of nomograms for predicting individual survival in patients with ovarian clear cell carcinoma.
Liu X; Lu H; Zhou Y; Long X; Li Q; Zhuang G; Yin X; Di W
Cancer Med; 2023 May; 12(10):11385-11395. PubMed ID: 36971044
[TBL] [Abstract][Full Text] [Related]
7. A prognostic model of patients with ovarian mucinous adenocarcinoma: a population-based analysis.
Yang L; Yu J; Zhang S; Shan Y; Li Y; Xu L; Zhang J; Zhang J
J Ovarian Res; 2022 Feb; 15(1):26. PubMed ID: 35168642
[TBL] [Abstract][Full Text] [Related]
8. Nomograms predicting the overall survival and cancer-specific survival of patients with stage IIIC1 cervical cancer.
Feng Y; Wang Y; Xie Y; Wu S; Li Y; Li M
BMC Cancer; 2021 Apr; 21(1):450. PubMed ID: 33892663
[TBL] [Abstract][Full Text] [Related]
9. Exploration and prognostic analysis of two types of high-risk ovarian cancers: clear cell vs. serous carcinoma: a population-based study.
Liu T; Gao Y; Li S; Xu S
J Ovarian Res; 2024 Jun; 17(1):119. PubMed ID: 38824600
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of a nomogram to predict the prognosis of patients with gastric cardia cancer.
Shi X; Xu L; Ma B; Wang S
Sci Rep; 2020 Aug; 10(1):14143. PubMed ID: 32839498
[TBL] [Abstract][Full Text] [Related]
11. Development and evaluation of nomograms and risk stratification systems to predict the overall survival and cancer-specific survival of patients with hepatocellular carcinoma.
Kang X; Liu X; Li Y; Yuan W; Xu Y; Yan H
Clin Exp Med; 2024 Feb; 24(1):44. PubMed ID: 38413421
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of prognostic nomograms for early-onset colon cancer in different tumor locations: a population-based study.
Zhu S; Tu J; Pei W; Zheng Z; Bi J; Feng Q
BMC Gastroenterol; 2023 Oct; 23(1):362. PubMed ID: 37865754
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of nomograms for predicting survival of elderly patients with stage I small-cell lung cancer.
Yang Y; Sun S; Wang Y; Xiong F; Xiao Y; Huang J
Bosn J Basic Med Sci; 2021 Oct; 21(5):632-641. PubMed ID: 33577444
[TBL] [Abstract][Full Text] [Related]
14. Nomograms for primary mucinous ovarian cancer: A SEER population-based study.
Qi X; Xu L; Wang J; Yu J; Wang Y
J Gynecol Obstet Hum Reprod; 2022 Sep; 51(7):102424. PubMed ID: 35697250
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of survival nomograms for patients with differentiated thyroid cancer with distant metastases: a SEER Program-based study.
Ma Q; Chen Z; Fang Y; Wei X; Wang N; Zhou X; Li S; Ying C
J Endocrinol Invest; 2024 Jan; 47(1):115-129. PubMed ID: 37294407
[TBL] [Abstract][Full Text] [Related]
16. Establishment and validation of nomogram models for overall survival and cancer-specific survival in spindle cell sarcoma patients.
Qi W; Ren Y; Wang H; Wan Y; Wang D; Yao J; Pan H
Sci Rep; 2023 Dec; 13(1):23018. PubMed ID: 38155261
[TBL] [Abstract][Full Text] [Related]
17. Nomograms and risk classification systems predicting overall and cancer-specific survival in primary malignant cardiac tumor.
Guan T; Li Y; Qiu Z; Zhang Y; Lin W; Lai Y; Wang K; Shen Y; Du L; Liu C
J Card Surg; 2019 Dec; 34(12):1540-1549. PubMed ID: 31794125
[TBL] [Abstract][Full Text] [Related]
18. A novel nomogram based on LODDS to predict the prognosis of epithelial ovarian cancer.
Xu XL; Cheng H; Tang MS; Zhang HL; Wu RY; Yu Y; Li X; Wang XM; Mai J; Yang CL; Jiao L; Li ZL; Zhong ZM; Deng R; Li JD; Zhu XF
Oncotarget; 2017 Jan; 8(5):8120-8130. PubMed ID: 28042955
[TBL] [Abstract][Full Text] [Related]
19. Novel prognostic nomograms to assess survival in high-grade serous ovarian carcinoma after surgery and chemotherapy: a retrospective cohort study from SEER database.
Huang W; Bao Y; Luo X; Yao L; Yuan L
Ann Transl Med; 2022 Jul; 10(13):728. PubMed ID: 35957727
[TBL] [Abstract][Full Text] [Related]
20. Competing risk nomogram and risk classification system for evaluating overall and cancer-specific survival in neuroendocrine carcinoma of the cervix: a population-based retrospective study.
Liu J; Lyu Y; He Y; Ge J; Zou W; Liu S; Yang H; Li J; Jiang K
J Endocrinol Invest; 2024 Jun; 47(6):1545-1557. PubMed ID: 38170396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
